Navigation Links
Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
Date:5/15/2008

LAIYANG, China, May 15 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GTEC) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced its financial results for the quarter ended March 31, 2008, the Company's third quarter of its fiscal year ended June 30, 2008. A 10QSB Form was filed for the quarter with the U.S. Securities Exchange Commission that is available through the Company's website and from the SEC.

Third Quarter 2008 Highlights:

-- Revenue totaled $28.1 million, up 48.5% year-over-year

-- Gross profit totaled $21.8 million, up 60.7% year-over-year

-- Gross margin was 77.4%, compared to 71.5% a year ago

-- Net income rose to $4.5 million, up 138.46% from the quarter ended

March 31, 2007, $0.01 per basic and diluted share

-- Engaged Moore Stephens Wurth Frazer & Torbet, LLP as independent

auditor

"We are pleased to report financial results that confirm the growing popularity of our products. Our best selling products continue to be Clarithromycin sustained-release tablets and Itopride Hydrochloride granules. Sales for Baobaole chewable tablets, our first Chinese herbal over the counter drug product, have grown rapidly since we introduced it at the end of 2007," said Mr. Cao Wubo, Chairman and CEO of Genesis Pharmaceuticals Enterprises, Inc. "We have several new drugs that are still in various stages of approval from China's State Food and Drug Administration, and we believe that we will be able to introduce four new drugs in the near future."

Third Quarter of Fiscal Year 2008 Results

Total revenue in the third quarter ended March 31, 2008 was $28.1 million, up 48.5% from $18.9 million in the prior year's period. This increase in revenue was mostly due to increased sales of the Company's two most popular products, Clarithromycin sustained-rel
'/>"/>

SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Cardiogenesis Reports First Quarter 2008 Results
2. Effect of mutant p53 stability on tumorigenesis and drug design
3. Cardiogenesis Corporation to Report 2008 First Quarter Results on May 15th
4. A stem cell type supposed to be crucial for angiogenesis and cancer growth does not exist?
5. Mitochondria play role in pathogenesis of AD and estrogen-induced neuroprotection
6. Science of Sri Vidya Benefits DNA Genesis, Says Dr. Sunita Rana Agarwal
7. Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
8. Genesis Pharmaceuticals Changes Auditors
9. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
10. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
11. Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... Mindful Her, a unique ... to take their healthy and mindful living practices to the next level, announced today ... of Living with Intent as keynote. Global Girls, an Orange County based non-profit ...
(Date:7/28/2015)... ... July 28, 2015 , ... The Denver Foundation and ... Reframed and Exhibited,” a photographic and narrative exploration of African American giving, which ... Points neighborhood. , Denver is one of only ten cities to host “The ...
(Date:7/28/2015)... ... 2015 , ... Representatives with CareMed Urgent & Primary Care ... National Immunization Awareness Month, which is the month of August. , “Immunization helps ... the flu, measles, and pneumonia, adults need to get their shots – just ...
(Date:7/28/2015)... FAIRFAX, Virginia (PRWEB) , ... July 28, 2015 , ... ... in the Washington, D.C. technology community for over 20 years, has selected Lisa Dezzutti, ... for the upcoming year. , “I am excited to serve this organization that empowers ...
(Date:7/28/2015)... Diego, California (PRWEB) , ... July 28, 2015 , ... ... more women consider the procedure to help ensure future fertility. As Dr. Michael ... June 2015), egg freezing is an option that wasn’t available for previous generations who ...
Breaking Medicine News(10 mins):Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3
... with mammography systems in the, early detection of ... false-positives and patient recalls by estimated 60 ... 14 Parascript, LLC, the image,analysis and pattern ... medical imaging market. With over a dozen years,experience ...
... voices of frustration from,those who live with the ... heard.,Recent studies suggest that the comprehensive and often ... the point,of inaction. Studies show that nearly 63% ... treatment goals. "Understanding the lengthy,and challenging process of ...
... Product Sales Total $3.1 Million in Quarter; Amoxicillin PULSYS ... Review Ongoing - PDUFA ... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical ... financial and operational results for the quarter ended September,30, ...
... NeoGenomics, Inc.,(OTC Bulletin Board: NGNM), a premier, high-complexity cancer ... of FY 2007.,Significant accomplishments during the third quarter and ... following: Third Quarter 2007 Accomplishments: -- 95% ... 06 -- 33% sequential growth in revenue from ...
... CTI,s new cancer drug development platform, SEATTLE, ... first-hand the progress and prospects of three of ... MTAX: CTIC) oncology drug,candidates, as well as information ... from an international panel of clinical investigators at ...
... ... Jordan, FREDERICK, Md., ... Jordan Food,& Drug Administration has cleared ActiPatch for sale. The Company has,initiated ... "We are proud to announce another step for our Company in ...
Cached Medicine News:Health News:Parascript Enters Medical Imaging Breast Cancer Detection Market With Established Image Analysis Technology 2Health News:Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment 2Health News:Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 2Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 4Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 5Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 6Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 7Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 8Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 9Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 10Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 11Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 12Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 13Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 14Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 2Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 3Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 4Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 5Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 6Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 7Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 8Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 2Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 3Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 4Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 5Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 6Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 7Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 8Health News:ActiPatch(TM) Granted Market Clearance by the Food & Drug Administration in the Kingdom of Jordan 2
(Date:7/28/2015)... 28, 2015 /PRNewswire-USNewswire/ -- Kentucky,s ... doctor shopping after a 2012 law required providers to ... medications is yet more evidence that Californians need the ... Since Kentucky,s prescription drug abuse ... declined by 52 percent; opioid prescriptions to doctor-shopping individuals ...
(Date:7/28/2015)... 2015  SeraCare Life Sciences, a leading partner ... at the American Association of Clinical Chemistry (AACC) ... with the University of California, San Francisco (UCSF) ... 18 (T18) and Trisomy 13 (T13) trophoblast cell ... reference materials for Non-Invasive Prenatal Testing (NIPT) of ...
(Date:7/28/2015)... , July 28, 2015   Vincari , known ... , has just hired John O,Neil as ... John has over 30 years of diverse and progressive ... O,Neil,s executive healthcare experience coupled with Vincari,s CMO, Dr. ... allows Vincari to address the challenges both hospitals and ...
Breaking Medicine Technology:Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2
... Surgical Company (Nasdaq: STAA ), a leading ... today announced that it expects revenue for the fourth ... Revenues for the full year were approximately $55 million, ... increase of approximately 10% in revenues from the core ...
... Nalco (NYSE: NLC ), providing essential ... Water and Process Services division is implementing a price ... or as contracts permit.  Pricing for most Nalco programs ... product mix. Price increases will vary by country and ...
Cached Medicine Technology:STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 2STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 4Nalco Announces Price Increase 2Nalco Announces Price Increase 3
Autolensmeter with black/white monitor and no internal printer....
An ideal basic fundus fluorescein camera with quality enhancing features at a mid-range price point. The camera has 1.7x magnification at 60 degree and 2.5x at 40 degree....
... The Tomey TL-2000A Auto Lensmeter is ... advanced lens measuring features. In Auto mode, ... lens is properly aligned. Progressive lenses are ... you to correctly position the lens. The ...
... RC-XV3 camera is practical, compact ... automatic exposure system, the 22 ... 2.5~300ws watt indication and the ... the basic features to make ...
Medicine Products: